atenolol has been researched along with dihydropyridines in 39 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 17 (43.59) | 18.2507 |
| 2000's | 17 (43.59) | 29.6817 |
| 2010's | 5 (12.82) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asano, M; Shibasaki, K; Uchida, W | 1 |
| Dohmoto, H; Fujiyoshi, T; Hashiguchi, Y; Hayashi, Y; Hosono, M; Iida, H; Ikeda, K; Yoshimoto, R | 1 |
| Dahlöf, B; Eggertsen, R; Hansson, L; Jern, S; Kullman, S; Scherstén, B; Sivertsson, R; Sörensen, S | 1 |
| Berdeaux, A; Drieu la Rochelle, C; Giudicelli, JF; Richard, V | 1 |
| Arakawa, K; Kajiyama, G; Kusukawa, R; Mashiba, H; Nonaka, K; Sasaki, J; Shichiri, M; Sunaga, T; Tanaka, N | 1 |
| Leonetti, G; Salvi, S | 1 |
| Bond, G; Dal Palú, C; Hansson, L; Magnani, B; Mancia, G; Neiss, A; Rahn, KH; Reid, JL; Rodicio, JL; Safar, M | 1 |
| Asano, M; Matsuda, Y; Shibasaki, K; Takenaka, T; Uchida, W | 1 |
| Fowler, G; Hall, ST; Lyons, D; Petrie, JC; Webster, J | 1 |
| Leonetti, G | 1 |
| Chrysant, S; Dunlay, MC; Fitzpatrick, V; Francischetti, EA; Goldberg, AI; Sweet, CS | 1 |
| Bond, MG; Mercuri, M | 1 |
| Inada, Y; Kanagawa, R; Nishikawa, K; Ojima, M; Sanada, T; Wada, T | 1 |
| Fischmeister, R; Hoerter, J; Hove-Madsen, L; Legssyer, AK | 1 |
| Bossi, M; Tiberti, G | 1 |
| Bond, MG; Dal Palù, C; Eckes, L; Hansson, L; Hennig, M; Magnani, B; Mancia, G; Neiss, A; Rahn, KH; Ravinetto, R; Reid, J; Rodicio, J; Safar, M; Zanchetti, A | 1 |
| Bond, MG; Catalini, R; Hennig, M; Ravinetto, R; Rubba, P; Scherz, R; Tang, R; Thomasson, B; Zanchetti, A | 1 |
| Hamm, C; Mitrovic, V; Oehm, E; Pitschner, H; Thormann, J | 1 |
| Einecke, D | 1 |
| Cominacini, L; Garbin, U; Ghiadoni, L; Magagna, A; Pasini, AF; Salvetti, A; Taddei, S; Virdis, A | 1 |
| Devereux, RB; Palmieri, V | 1 |
| Bond, MG; Dal Palù, C; Eckes, L; Hansson, L; Hennig, M; Magnani, B; Mancia, G; Neiss, A; Rahn, KH; Reid, JL; Rizzini, P; Rodicio, J; Safar, M; Zanchetti, A | 1 |
| Abil'dinova, AZh; Glezer, MG | 1 |
| Bond, MG; Eckes, L; Hennig, M; Hollweck, R; Mancia, G; Micheli, D; Tang, R; Zanchetti, A | 1 |
| Bond, G; Failla, M; Giannattasio, C; Hennig, M; Hollweck, R; Laurent, S; Mallion, JM; Mancia, G; Reid, J; Safar, M; Zanchetti, A | 1 |
| Corradi, L; Fogari, E; Fogari, R; Lazzari, P; Mugellini, A; Rinaldi, A; Zoppi, A | 1 |
| Agabiti-Rosei, E; Baurecht, H; Hennig, M; Mancia, G; Muiesan, ML; Parati, G; Reid, J; Salvetti, A; Tang, R; Trimarco, B; Zanchetti, A | 1 |
| Bond, MG; Ciulla, MM; Hennig, M; Magrini, F; Mancia, G; Paliotti, R; Tang, R; Zanchetti, A | 1 |
| Burnier, M; Pechère, A; Waeber, B | 1 |
| Baurecht, H; Bilo, G; Hennig, M; Mancia, G; Maronati, A; Omboni, S; Parati, G; Zanchetti, A | 1 |
| Baurecht, H; Carugo, S; Cuspidi, C; Hennig, M; Mancia, G; Tang, R; Zanchetti, A | 1 |
| Brown, MJ; Cockcroft, JR; Dhakam, Z; Mackenzie, IS; McEniery, CM; Wilkinson, IB | 1 |
| Barbosa, L; Bertoquini, S; Polónia, J; Silva, JA | 1 |
| Facchetti, R; Mancia, G; Parati, G; Zanchetti, A | 2 |
| Brown, I; Gallivan, C | 1 |
| Bombelli, M; Cuspidi, C; Facchetti, R; Grassi, G; Macchiarulo, M; Maggiolini, D; Mancia, G; Parati, G | 1 |
1 review(s) available for atenolol and dihydropyridines
| Article | Year |
|---|---|
Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Dihydropyridines; Disease Models, Animal; Diuretics; Drug Therapy, Combination; Enalapril; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Meta-Analysis as Topic; Nifedipine; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Sodium Chloride Symporter Inhibitors; Time Factors; Ventricular Dysfunction, Left | 2002 |
25 trial(s) available for atenolol and dihydropyridines
| Article | Year |
|---|---|
Swedish Isradipine Study in Hypertension: evaluation of quality of life, safety, and efficacy. SWISH Group.
Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Double-Blind Method; Humans; Hypertension; Isradipine; Middle Aged; Prospective Studies; Quality of Life; Safety; Sweden | 1991 |
A double-blind comparison of the efficacy and safety of lacidipine with atenolol in the treatment of essential hypertension. The United Kingdom Lacidipine Study Group.
Topics: Adult; Aged; Atenolol; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Safety | 1991 |
Effects of a new calcium channel blocker, MPC-1304, on blood pressure, serum lipoproteins and serum carbohydrate metabolism in patients with essential hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Apolipoprotein A-II; Apolipoproteins; Atenolol; Blood Glucose; Blood Pressure; C-Peptide; Calcium Channel Blockers; Dihydropyridines; Heart Rate; Hemoglobins; Humans; Hypertension; Insulin; Lipoproteins; Middle Aged; Treatment Outcome | 1995 |
A long-term study comparing lacidipine and nifedipine SR in hypertensive patients: safety data.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Calcium Channel Blockers; Delayed-Action Preparations; Dihydropyridines; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nifedipine; Single-Blind Method | 1994 |
The E.L.S.A. trial: protocol of a randomized trial to explore the differential effect of antihypertensive drugs on atherosclerosis in hypertension.
Topics: Aged; Antihypertensive Agents; Arteriosclerosis; Atenolol; Dihydropyridines; Double-Blind Method; Humans; Hypertension; Middle Aged | 1994 |
An assessment of lacidipine and atenolol in mild to moderate hypertension.
Topics: Adult; Antihypertensive Agents; Atenolol; Blood Pressure; Dihydropyridines; Double-Blind Method; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Exercise; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Pulse | 1994 |
[The preliminary clinical evidence from the ELSA study. The European Lacidipine Study on Atherosclerosis].
Topics: Aged; Antihypertensive Agents; Arteriosclerosis; Atenolol; Calcium Channel Blockers; Carotid Artery Diseases; Delayed-Action Preparations; Dihydropyridines; Double-Blind Method; Europe; Humans; Hypertension; Middle Aged | 1995 |
Losartan potassium as initial therapy in patients with severe hypertension.
Topics: Adolescent; Adult; Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Dihydropyridines; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Losartan; Male; Middle Aged; Renin-Angiotensin System; Tetrazoles; Treatment Outcome | 1995 |
Potential modification of plaque behavior through the European lacidipine study on atherosclerosis.
Topics: Adrenergic beta-Antagonists; Arteriosclerosis; Atenolol; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Carotid Arteries; Dihydropyridines; Double-Blind Method; Europe; Humans; Hypertension; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Ultrasonography | 1995 |
Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis.
Topics: Adrenergic beta-Antagonists; Aged; Arteriosclerosis; Atenolol; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Carotid Arteries; Dihydropyridines; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Risk Factors; Ultrasonography | 1998 |
Baseline reproducibility of B-mode ultrasonic measurement of carotid artery intima-media thickness: the European Lacidipine Study on Atherosclerosis (ELSA).
Topics: Adrenergic beta-Antagonists; Arteriosclerosis; Atenolol; Calcium Channel Blockers; Carotid Arteries; Dihydropyridines; Double-Blind Method; Europe; Humans; Observer Variation; Prospective Studies; Quality Control; Reproducibility of Results; Ultrasonography | 2000 |
Potassium channel openers and blockers in coronary artery disease. Comparison to betablockers and calcium antagonists.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Angina Pectoris; Anti-Arrhythmia Agents; Atenolol; Benzopyrans; Bridged Bicyclo Compounds, Heterocyclic; Calcium Channel Blockers; Cardiotonic Agents; Coronary Disease; Cyclopropanes; Dihydropyridines; Electrocardiography; Exercise Test; Gallopamil; Hemodynamics; Humans; Middle Aged; Myocardium; Oxygen Consumption; Potassium Channel Blockers; Potassium Channels; Propanolamines; Time Factors; Vasodilator Agents | 2000 |
Effect of calcium antagonist or beta blockade treatment on nitric oxide-dependent vasodilation and oxidative stress in essential hypertensive patients.
Topics: Adrenergic beta-Antagonists; Adult; Antioxidants; Atenolol; Biological Availability; Biomarkers; Calcium Channel Blockers; Dihydropyridines; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Nitric Oxide; Oxidative Stress; Vasodilation | 2001 |
Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Atenolol; Blood Pressure; Calcium Channel Blockers; Carotid Arteries; Carotid Artery Diseases; Dihydropyridines; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Time; Treatment Outcome; Tunica Intima; Tunica Media; Ultrasonography | 2002 |
Absolute and relative changes in carotid intima-media thickness and atherosclerotic plaques during long-term antihypertensive treatment: further results of the European Lacidipine Study on Atherosclerosis (ELSA).
Topics: Aged; Antihypertensive Agents; Atenolol; Carotid Artery Diseases; Carotid Artery, Common; Carotid Artery, Internal; Dihydropyridines; Disease Progression; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Time Factors; Tunica Intima; Tunica Media; Ultrasonography | 2004 |
Different relation between 24-h blood pressure and distensibility at different peripheral arteries. Data from the European Lacidipine Study on Atherosclerosis (ELSA).
Topics: Antihypertensive Agents; Arteriosclerosis; Atenolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Carotid Artery, Common; Circadian Rhythm; Dihydropyridines; Europe; Female; Humans; Hypertension; Male; Middle Aged; Radial Artery; Ultrasonography | 2005 |
Effect of manidipine as compared to atenolol on platelet aggregation in elderly patients with isolated systolic hypertension and type II diabetes mellitus.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Atenolol; Cross-Over Studies; Diabetes Mellitus, Type 2; Dihydropyridines; Double-Blind Method; Female; Humans; Hypertension; Male; Nitrobenzenes; Piperazines; Platelet Aggregation | 2005 |
Cardiac structural and functional changes during long-term antihypertensive treatment with lacidipine and atenolol in the European Lacidipine Study on Atherosclerosis (ELSA).
Topics: Adult; Aged; Atenolol; Dihydropyridines; Echocardiography; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Multivariate Analysis; Systole; Ventricular Function, Left | 2005 |
Carotid wall composition in hypertensive patients after 4-year treatment with lacidipine or atenolol: an echoreflectivity study.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Carotid Arteries; Carotid Artery Diseases; Dihydropyridines; Female; Humans; Hypertension; Male; Middle Aged; Reproducibility of Results; Tunica Intima; Tunica Media; Ultrasonography | 2005 |
Assessment of long-term antihypertensive treatment by clinic and ambulatory blood pressure: data from the European Lacidipine Study on Atherosclerosis.
Topics: Antihypertensive Agents; Atenolol; Atherosclerosis; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Dihydropyridines; Female; Humans; Hypertension; Male; Middle Aged | 2007 |
Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima-media thickness.
Topics: Aged; Antihypertensive Agents; Atenolol; Atherosclerosis; Calcium Channel Blockers; Carotid Arteries; Cohort Studies; Diabetes Complications; Dihydropyridines; Europe; Female; Humans; Hypertension; Male; Metabolic Syndrome; Middle Aged | 2007 |
Comparison of the effects of antihypertensive agents on central blood pressure and arterial stiffness in isolated systolic hypertension.
Topics: Administration, Oral; Aged; Analysis of Variance; Antihypertensive Agents; Arteries; Atenolol; Bendroflumethiazide; Blood Pressure Determination; Dihydropyridines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Elasticity; Female; Follow-Up Studies; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Multivariate Analysis; Patient Compliance; Perindopril; Probability; Regression Analysis; Risk Assessment; Systole; Treatment Outcome | 2009 |
Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study on Atherosclerosis.
Topics: Adrenergic Antagonists; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Carotid Artery Diseases; Carotid Intima-Media Thickness; Circadian Rhythm; Dihydropyridines; Double-Blind Method; Europe; Female; Humans; Hypertension; Incidence; Male; Middle Aged; Office Visits; Prognosis; Prospective Studies; Treatment Outcome | 2012 |
Effect of long-term antihypertensive treatment on white-coat hypertension.
Topics: Aged; Atenolol; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mutagens; Prospective Studies; Time Factors; Treatment Outcome; White Coat Hypertension | 2014 |
Serum uric acid and resistance to antihypertensive treatment: data from the European Lacidipine Study on Atherosclerosis.
Topics: Antihypertensive Agents; Atenolol; Atherosclerosis; Blood Pressure; Carotid Artery Diseases; Dihydropyridines; Disease Progression; Double-Blind Method; Drug Resistance; Female; Humans; Hypertension; Male; Middle Aged; Uric Acid | 2019 |
13 other study(ies) available for atenolol and dihydropyridines
| Article | Year |
|---|---|
Cardiovascular effects of a novel calcium entry blocking and selective beta 1-adrenoceptor blocking agent, YM-16151-4, in anesthetized and conscious dogs.
Topics: Adrenergic beta-Antagonists; Anesthesia; Animals; Atenolol; Blood Pressure; Calcium Channel Blockers; Coronary Circulation; Coronary Vessels; Dihydropyridines; Dogs; Dose-Response Relationship, Drug; Female; Heart Conduction System; Heart Rate; Hemodynamics; Male; Nifedipine; Nitrophenols; Vagotomy; Vasodilator Agents | 1992 |
Effects of a new dihydropyridine derivative, FRC-8653, on blood pressure in conscious spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Captopril; Dihydropyridines; Heart Rate; Hydrochlorothiazide; Hypertension; Male; Rats; Rats, Inbred SHR | 1992 |
Coronary effects of a combined beta adrenoceptor blocking and calcium antagonist therapy in running dogs.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Calcium Channel Blockers; Coronary Vessels; Dihydropyridines; Dogs; Hemodynamics; Nicardipine; Nitrophenols; Running | 1991 |
Cardiovascular effects of YM-16151-4: a novel calcium entry blocking and selective beta 1-adrenoceptor blocking agent in rats and dogs.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Dogs; Heart Rate; Hemodynamics; Male; Nifedipine; Nitrophenols; Rats; Rats, Wistar; Renin | 1993 |
Combined effects of the angiotensin II antagonist candesartan cilexetil (TCV-116) and other classes of antihypertensive drugs in spontaneously hypertensive rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin II; Animals; Antihypertensive Agents; Atenolol; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Dihydropyridines; Diuretics; Drug Therapy, Combination; Hydrochlorothiazide; Male; Nitrobenzenes; Piperazines; Prazosin; Rats; Rats, Inbred SHR; Renin; Sodium Chloride Symporter Inhibitors; Tetrazoles | 1996 |
Sympathetic modulation of the effect of nifedipine on myocardial contraction and Ca current in the rat.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Dihydropyridines; Heart Ventricles; Hypertension; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Myocardial Reperfusion; Nifedipine; Patch-Clamp Techniques; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, beta; Sympatholytics; Sympathomimetics; Ventricular Function | 1997 |
[Stable angina pectoris: what is the role of calcium antagonists?].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Atenolol; Calcium Channel Blockers; Clinical Trials as Topic; Dihydropyridines; Diltiazem; Drug Therapy, Combination; Felodipine; Humans; Metoprolol; Multicenter Studies as Topic; Nifedipine; Randomized Controlled Trials as Topic; Verapamil | 1997 |
[ELSA Studies studies progression of atherosclerosis. Calcium antagonist arrests the process more than a beta-blocker].
Topics: Adrenergic beta-Antagonists; Arteriosclerosis; Atenolol; Calcium Channel Blockers; Dihydropyridines; Disease Progression; Humans; Hypertension; Randomized Controlled Trials as Topic | 2001 |
[Calcium antagonists lower not only blood pressure. Arteriosclerosis is braked too].
Topics: Aged; Antihypertensive Agents; Arteriosclerosis; Atenolol; Calcium Channel Blockers; Carotid Stenosis; Dihydropyridines; Double-Blind Method; Humans; Hypertension; Middle Aged; Prospective Studies; Randomized Controlled Trials as Topic; Time Factors; Ultrasonography, Doppler, Color | 2001 |
[The use of combination therapy with lacidipine and beta-adrenoblockers in patients with hypertension].
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Blood Pressure; Dihydropyridines; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Metoprolol; Middle Aged; Treatment Outcome | 2002 |
[Antihypertensive agents used as first line agents: beta-blockers under pressure].
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Dihydropyridines; Diuretics; Drug Therapy, Combination; Eplerenone; Humans; Hypertension; Spironolactone; Treatment Outcome | 2006 |
Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Aorta; Atenolol; Benzopyrans; Blood Flow Velocity; Blood Pressure; Brachial Artery; Calcium Channel Blockers; Carbazoles; Carvedilol; Dihydropyridines; Diuretics; Ethanolamines; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nebivolol; Propanolamines; Pulsatile Flow; Retrospective Studies; Vascular Resistance; Vasodilator Agents | 2010 |
Olmesartan induced enterocolitis.
Topics: Aged; Amitriptyline; Anticholesteremic Agents; Antidepressive Agents, Tricyclic; Antihypertensive Agents; Atenolol; Atorvastatin; Dihydropyridines; Enterocolitis; Female; Heptanoic Acids; Humans; Imidazoles; Pyrroles; Tetrazoles | 2014 |